Nuvation Bio (NUVB) Stock Forecast & Price Target

Compare

341 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NUVB Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Nuvation

Bio

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NUVB Stock 12 Month Forecast

Average Price Target

$8.20

▲(373.99%Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Nuvation Bio in the last 3 months. The average price target is $8.20 with a high forecast of $10.00 and a low forecast of $5.00. The average price target represents a 373.99% change from the last price of $1.73.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","11":"$11","2.75":"$2.75","5.5":"$5.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.75,5.5,8.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.34,2.9292307692307693,3.5184615384615383,4.107692307692307,4.696923076923077,5.286153846153846,5.875384615384615,6.464615384615384,7.053846153846154,7.643076923076923,8.232307692307693,8.821538461538461,9.41076923076923,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.34,2.7907692307692304,3.241538461538461,3.692307692307692,4.143076923076922,4.593846153846153,5.044615384615384,5.495384615384615,5.9461538461538455,6.396923076923076,6.847692307692307,7.298461538461537,7.749230769230769,{"y":8.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.34,2.5446153846153843,2.749230769230769,2.9538461538461536,3.1584615384615384,3.363076923076923,3.5676923076923073,3.772307692307692,3.976923076923077,4.181538461538461,4.386153846153846,4.590769230769231,4.795384615384615,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.1,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.16,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.55,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.22,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.3,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.3,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.98,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.66,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.31,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.97,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.75,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.27,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.34,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$10.00

Average Price Target$8.20

Lowest Price Target$5.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Robert BurnsH.C. Wainwright

H.C. Wainwright

$10

Buy

478.03%

Upside

Reiterated

06/13/25

Buy Rating for Nuvation Bio's IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment

Silvan TuerkcanCitizens JMP

Citizens JMP

Buy

246.82%

Upside

Reiterated

06/12/25

Citizens JMP reiterates Market Outperform Rating on Nuvation Bio Inc (NUVB)Citizens JMP analyst Silvan Tuerkcan reiterated a Market Outperform rating and $6.00 price target on Nuvation Bio Inc (NYSE: NUVB).

Soumit RoyJonesTrading

JonesTrading

$10

Buy

478.03%

Upside

Reiterated

06/12/25

Warnings for Nuvation's Ibtrozi as expected, says JonesResearchWarnings for Nuvation's Ibtrozi as expected, says JonesResearch

Yaron WerberTD Cowen

TD Cowen

―

Buy

―

Reiterated

06/11/25

Analysts' Top Healthcare Picks: Liquidia Technologies (LQDA), Cabaletta Bio (CABA)

David NierengartenWedbush

Wedbush

Buy

189.02%

Upside

Reiterated

05/16/25

Nuvation Bio (NUVB) Gets a Buy from Wedbush

Gregory RenzaRBC Capital

RBC Capital

$10

Buy

478.03%

Upside

Reiterated

05/07/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Michael YeeJefferies

Jefferies

$10

Buy

478.03%

Upside

Assigned

09/16/24

Jefferies Releases a Buy Rating on Nuvation Bio (NUVB)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Robert BurnsH.C. Wainwright

H.C. Wainwright

$10

Buy

478.03%

Upside

Reiterated

06/13/25

Buy Rating for Nuvation Bio's IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment

Silvan TuerkcanCitizens JMP

Citizens JMP

Buy

246.82%

Upside

Reiterated

06/12/25

Soumit RoyJonesTrading

JonesTrading

$10

Buy

478.03%

Upside

Reiterated

06/12/25

Warnings for Nuvation's Ibtrozi as expected, says JonesResearchWarnings for Nuvation's Ibtrozi as expected, says JonesResearch

Yaron WerberTD Cowen

TD Cowen

―

Buy

―

Reiterated

06/11/25

Analysts' Top Healthcare Picks: Liquidia Technologies (LQDA), Cabaletta Bio (CABA)

David NierengartenWedbush

Wedbush

Buy

189.02%

Upside

Reiterated

05/16/25

Nuvation Bio (NUVB) Gets a Buy from Wedbush

Gregory RenzaRBC Capital

RBC Capital

$10

Buy

478.03%

Upside

Reiterated

05/07/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Michael YeeJefferies

Jefferies

$10

Buy

478.03%

Upside

Assigned

09/16/24

Jefferies Releases a Buy Rating on Nuvation Bio (NUVB)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Nuvation Bio

1 Month

xxx

Success Rate

5/11 ratings generated profit

Average Return

+3.20%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 45.45% of your transactions generating a profit, with an average return of +3.20% per trade.

3 Months

xxx

Success Rate

8/16 ratings generated profit

Average Return

-0.37%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.37% per trade.

1 Year

Gregory RenzaRBC Capital

Success Rate

5/16 ratings generated profit

Average Return

-2.83%

reiterated a buy rating last month

Copying Gregory Renza's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of -2.83% per trade.

2 Years

xxx

Success Rate

5/16 ratings generated profit

Average Return

-8.36%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 31.25% of your transactions generating a profit, with an average return of -8.36% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NUVB Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NUVB has received 16 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NUVB average Analyst price target in the past 3 months is 8.20.

Each month's total comprises the sum of three months' worth of ratings.

NUVB Financial Forecast

NUVB Earnings Forecast

Next quarter’s earnings estimate for NUVB is -$0.16 with a range of -$0.19 to -$0.12. The previous quarter’s EPS was -$0.16. NUVB beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 43.18% of the time in the same period. In the last calendar year NUVB has Preformed in-line its overall industry.

NUVB Sales Forecast

Next quarter’s sales forecast for NUVB is $357.00K with a range of $0.00 to $2.50M. The previous quarter’s sales results were $3.08M. NUVB beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 56.92% of the time in the same period. In the last calendar year NUVB has Outperformed its overall industry.

NUVB Stock Forecast FAQ

What is NUVB’s average 12-month price target, according to analysts?

Based on analyst ratings, Nuvation Bio’s 12-month average price target is 8.20.

What is NUVB’s upside potential, based on the analysts’ average price target?

Nuvation Bio has 373.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is NUVB a Buy, Sell or Hold?

Nuvation Bio has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is Nuvation Bio’s price target?

The average price target for Nuvation Bio is 8.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $5.00. The average price target represents 373.99% Increase from the current price of $1.73.

What do analysts say about Nuvation Bio?

Nuvation Bio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of NUVB?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Nuvation Bio (NUVB) Stock Forecast & Price Target

NUVB Analyst Ratings

NUVB Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Nuvation Bio

NUVB Analyst Recommendation Trends

NUVB Financial Forecast

NUVB Earnings Forecast

NUVB Sales Forecast

NUVB Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts